The plasma P-SH levels were found to be lower in HD patients not receiving intravenous iron or recombinant human erythropoietin vs. healthy controls [99]; however, this study did not specify whether the HD patients were normoalbuminemic or hypoalbuminemic. This evidence concerns the gene EPO and Huntington disease.